Robinhood Markets heads into the final weeks of September with a striking split: the stock is up 31% in a month and analysts are tripping over themselves to raise targets, yet short sellers have been quietly rebuilding positions at the fastest weekly pace in recent memory.
The most interesting tension this week isn't the rally — it's what's happening underneath it. Short interest climbed 17.5% in the past week alone, reaching 4.7% of the free float with roughly 36.8 million shares borrowed. That's a meaningful acceleration; over the prior month the cumulative rise was only 9.6%, meaning this week's move represents a sharp step-up in bearish conviction. The ORTEX short score has drifted higher too, edging from 35.2 on September 9 to 37.6 by September 17 — not an extreme reading, but a consistent trend in the more cautious direction as the stock itself surged. Short sellers appear to be fading the rally rather than retreating from it.
The borrow market tells a less alarming story for those shorts, however. Availability remains exceptionally loose at roughly 1,242% — meaning for every share already borrowed, more than twelve remain available in the lending pool. That's down sharply from 1,831% ten days ago as borrowing demand picks up, but it's still well within the normal-to-loose range, and cost to borrow is a negligible 0.47%. There is no squeeze mechanism at work here. Options positioning is similarly relaxed. The put/call ratio of 0.66 sits just below one standard deviation above its 20-day mean of 0.65 — barely elevated, consistent with a market that is mildly more cautious than usual but not defensively positioned.
The Street has leaned hard into the bull case. Goldman Sachs lifted its target from $124 to $142 on September 8, maintaining Buy. That same day Jefferies raised to $140 from $127, and Cantor Fitzgerald made the most aggressive move, lifting to $150 from $115. Since then Deutsche Bank raised to $138 on September 14 and Citizens pushed to $165 on September 11. StoneX initiated fresh coverage with a $170 Buy. The mean analyst target across the consensus now sits at $129, which — against a closing price of $119.82 — implies modest further Street-acknowledged upside. However, several of those targets already lag the stock's current price: Goldman's $142, Mizuho's $140, Jefferies' $140 are all within 20% of where the stock trades right now, suggesting some of the analyst enthusiasm is already in the price. The analyst recommendation differential factor score ranks in the 99th percentile, and EPS momentum ranks even higher at 97th percentile over 90 days — the earnings growth story remains intact. The bull case centres on tokenization, Robinhood Chain, and the platform's expanding financial services suite; the bear case flags regulatory exposure and the complexity of crypto-adjacent product dependencies.
Institutional flows add nuance to the ownership picture. BlackRock added 4.3 million shares last month, bringing its stake to 7.5%. FMR (Fidelity) is the most aggressive recent buyer, adding 10.3 million shares to reach 3.0% of outstanding. JP Morgan Asset Management added 1.8 million. On the other side, co-founder Baiju Bhatt sold roughly $2.8 million of stock on September 10 — though all under a pre-arranged 10b5-1 plan, which limits the signal value. CFO Shiv Verma similarly sold around $1.3 million on September 15 through the same mechanism. Net insider selling over 90 days totals approximately $16.4 million across 151,735 shares, but the 10b5-1 context makes this a compensation-mechanics story rather than a conviction signal.
Next up is the Q3 earnings report scheduled for November 4. The most recent print, on July 29, saw the stock fall 6.6% the following day before recovering almost entirely over five days. Whether a repeat depends on how the Street receives progress on Robinhood Chain, international expansion, and whether trading volumes held through a volatile September — all of which the rebuilding short position appears to be betting against.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
